comes as the GLP-1 analogues market, valued at USD 62.8 billion (EUR 54.4 billion) in 2024, is projected to grow 17.6 percent annually to reach USD 299 billion (EUR 259 billion) by 2033, according to DataM Intelligence 4 Market Research
Reduced food and fluid intake due to appetite suppression further decreases stool bulk and moisture, contributing to constipation
Most of the clinical benefit comes at doses of 1.0 mg and above
And once it becomes part of your routine, the wait feels a lot less noticeable
It is not appropriate for individuals with personal or family history of medullary thyroid cancer, type 2 multiple endocrine neoplasia (MEN2), severe pancreatitis history, or severe gastroparesis
10.1016/s0306-4522(98)00178-x 98 PapakyriakouA.ZervoudiE.TsoukalidouS.MauvaisF.-X.SfyroeraG.MastellosD